Evidence map›Paper›PMID 32528878›Full record

ArticleFrontiers in oncology2020

Normal Hematopoetic Stem and Progenitor Cells Can Exhibit Metabolic Flexibility Similar to Cancer Cells.

Marija Vlaski-Lafarge, Veronique Labat, Alexandra Brandy, Alice Refeyton, Pascale Duchez, Laura Rodriguez, Nyere Gibson, Philippe Brunet de la Grange, Zoran Ivanovic

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Cancer stem cells and their role in metastasis.Central European journal of urology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marija Vlaski-LafargeR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Veronique LabatR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Alexandra BrandyR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Alice RefeytonR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Pascale DuchezR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Laura RodriguezR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Nyere GibsonR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Philippe Brunet de la GrangeR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Zoran IvanovicR&D Department, Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France.
Université de Bordeaux · FRÉtablissement Français du Sang · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that cancer stem cells (CSCs) with the largest proliferative capacity survive the anoxic and/or ischemic conditions present inside tumorous tissue. In this study we test whether normal stem cells can survive under the same conditions due to cancer cell-like metabolic adaptations. We cultivated a CD34

Indexed as

bioenergeticscancer stem cellshematopoietic stem cellsmetabolismmitochondrial respiration

Identifiers

PMID32528878
PMCPMC7247845
OpenAlexW3024778689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.